BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17397381)

  • 1. Lesions attributed to vaccination of sheep with Gudair for the control of ovine paratuberculosis: post farm economic impacts at slaughter.
    Eppleston J; Windsor PA
    Aust Vet J; 2007 Apr; 85(4):129-33. PubMed ID: 17397381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is vaccination a viable method to control Johne's disease caused by Mycobacterium avium subsp. paratuberculosis? Data from 12 million ovine vaccinations and 7.6 million carcass examinations in New South Wales, Australia from 1999-2009.
    Links IJ; Denholm LJ; Evers M; Kingham LJ; Greenstein RJ
    PLoS One; 2021; 16(6):e0246411. PubMed ID: 34125838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a killed vaccine for the control of paratuberculosis in Australian sheep flocks.
    Reddacliff L; Eppleston J; Windsor P; Whittington R; Jones S
    Vet Microbiol; 2006 Jun; 115(1-3):77-90. PubMed ID: 16459030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial modelling of the potential cost of ovine Johne's disease and the benefit of vaccinating sheep flocks in southern New South Wales.
    Bush RD; Windsor PA; Toribio JA; Webster SR
    Aust Vet J; 2008 Oct; 86(10):398-403. PubMed ID: 18826512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of novel lipid-formulated whole bacterial cell vaccines against Mycobacterium avium subsp. paratuberculosis in sheep.
    Griffin JF; Hughes AD; Liggett S; Farquhar PA; Mackintosh CG; Bakker D
    Vaccine; 2009 Feb; 27(6):911-8. PubMed ID: 19059295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions in sheep following administration of a vaccine of a Freund's complete adjuvant nature used in the control of ovine paratuberculosis.
    Windsor PA; Eppleston J
    N Z Vet J; 2006 Oct; 54(5):237-41. PubMed ID: 17028662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losses of adult sheep due to ovine Johne's disease in 12 infected flocks over a 3-year period.
    Bush RD; Windsor PA; Toribio JA
    Aust Vet J; 2006 Jul; 84(7):246-53. PubMed ID: 16879127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of mycophage therapy, chemotherapy and vaccination for control of Mycobacterium avium subsp. paratuberculosis infection.
    Emery DL; Whittington RJ
    Vet Microbiol; 2004 Dec; 104(3-4):143-55. PubMed ID: 15564023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ovine Johne's disease in infected sheep flocks in Australia.
    Dhand NK; Eppleston J; Whittington RJ; Toribio JA
    Prev Vet Med; 2007 Nov; 82(1-2):51-71. PubMed ID: 17602766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in prevalence of ovine paratuberculosis following vaccination with Gudair®: Results of a longitudinal study conducted over a decade.
    Dhand NK; Eppleston J; Whittington RJ; Windsor PA
    Vaccine; 2016 Sep; 34(42):5107-5113. PubMed ID: 27614780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Gudairâ„¢ vaccine for the control of ovine Johne's disease in flocks vaccinating for at least 5 years.
    Windsor PA; Eppleston J; Dhand NK; Whittington RJ
    Aust Vet J; 2014 Jul; 92(7):263-8. PubMed ID: 24964836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross species transmission of ovine Johne's disease from sheep to cattle: an estimate of prevalence in exposed susceptible cattle.
    Moloney BJ; Whittington RJ
    Aust Vet J; 2008 Apr; 86(4):117-23. PubMed ID: 18363982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of farm soil characteristics with ovine Johne's disease in Australia.
    Dhand NK; Eppleston J; Whittington RJ; Toribio JA
    Prev Vet Med; 2009 May; 89(1-2):110-20. PubMed ID: 19321215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the effectiveness of the Gudair vaccine for controlling Johne's disease in sheep flocks in Australia.
    Dhand NK; Plain KM; Green AC; Martinez E; Eppleston J; Ly A; Arif S; Emery D
    Prev Vet Med; 2021 Aug; 193():105394. PubMed ID: 34119857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuity in ovine Johne's disease vaccination practices despite a decline in clinical disease.
    Green AC; Plain KM; Eppleston J; Martinez E; Emery D; Dhand NK
    Aust Vet J; 2021 Sep; 99(9):392-394. PubMed ID: 34080178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of methods to estimate the prevalence of ovine Johne's infection from pooled faecal samples.
    Toribio JA; Sergeant ES
    Aust Vet J; 2007 Aug; 85(8):317-24. PubMed ID: 17685977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune reactions to and side effects of a vaccination against paratuberculosis in milk goats].
    Stau A; Ganter M
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2012; 40(1):14-20. PubMed ID: 22331286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional study of risk factors for the clinical expression of ovine Johne's disease on New South Wales farms.
    Lugton IW
    Aust Vet J; 2004 Jun; 82(6):355-65. PubMed ID: 15267095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing control programs for ovine caseous lymphadenitis and paratuberculosis in Australia, and the need for persistent vaccination.
    Windsor PA
    Vet Med (Auckl); 2014; 5():11-22. PubMed ID: 32670842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines.
    Stanford K; Brogden KA; McClelland LA; Kozub GC; Audibert F
    Can J Vet Res; 1998 Jan; 62(1):38-43. PubMed ID: 9442938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.